C0596402||Cytotoxic
C1524058||antimigratory effects
C1219382||Cratoxy formosum
C0032081||extract
C2717940||HepG2
C2717940||liver cancer cells
C2603343||study
C1148560||molecular mechanisms
C1219382||Cratoxylum formosum
C1219382||Cratoxylum formosum
C0006826||cancer
C0007587||cell death
C1524058||antimigratory effects
C2717940||HepG2
C2717940||liver cancer cells
C0596402||cytotoxic
C1156236||antiproliferative
C1524058||antimigratory effects
C1219382||Cratoxylum formosum
C0032081||leaf extract
C0086418||human
C0345904||liver cancer
C2717940||HepG2 cell lines
C0065078||sulforhodamine B
C0009385||colony formation
C0005507||wound healing assays
C0162638||apoptosis
C1148560||induction mechanisms
C1148560||reactive oxygen species (ROS) formation
C1150132||caspase 3 activities
C1720920||mitochondrial membrane potential
C1720920||ΔΨm
C0017262||Gene expression
C0033684||apoptosis -associated protein
C0599161||reverse transcription-quantitative polymerase chain reaction
C0005863||western blotting
C1219382||Cratoxylum formosum
C2717940||HepG2
C0007587||cell death
C0087111||Treatment
C1219382||Cratoxylum formosum
C1622501||cell migration
C2603343||study
C1219382||Cratoxylum formosum
C1148560||ROS formation
C1150132||caspase 3 activities
C1720920||ΔΨm
C2717940||HepG2
C0162638||apoptosis
C1219382||Cratoxylum formosum
C0674679||cell cycle regulatory protein
C0139880||ras-related C3 botulinum toxin substrate 1
C0139880||small GTP binding protein Rac1
C0033684||downstream protein
C0252132||cyclin dependent kinase 6
C1219382||Cratoxylum formosum
C0288472||p21
C0033684||cyclin D1 protein
C0006826||cancer
C0007587||cell death
C1219382||Cratoxylum formosum
C0032081||leaf extracts
C0007587||cell death
C0162638||apoptosis
C1622501||migration
C2717940||HepG2 cells
C1219382||Cratoxylum formosum
C0003392||anticancer drug candidate
C0087111||treatment
C0345904||liver cancer